Shang Yao

London, ENG W120NN, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Retraction Note to: FOXM1 modulates 5-fluorouracil sensitivity in cholangiocarcinoma through thymidylate synthase (TYMS): implications of FOXM1-TYMS axis uncoupling in 5-FU resistance.

Retraction Note to: FOXM1 modulates 5-fluorouracil sensitivity in cholangiocarcinoma through thymidylate synthase (TYMS): implications of FOXM1-TYMS axis uncoupling in 5-FU resistance.

Journal: Cell death & disease
Published: May 26, 2021

A Splice Variant of NCOR2, BQ323636.1, Confers Chemoresistance in Breast Cancer by Altering the Activity of NRF2.

A Splice Variant of NCOR2, BQ323636.1, Confers Chemoresistance in Breast Cancer by Altering the Activity of NRF2.

Journal: Cancers
Published: December 14, 2019

Lapatinib sensitivity in nasopharyngeal carcinoma is modulated by SIRT2-mediated FOXO3 deacetylation.

Lapatinib sensitivity in nasopharyngeal carcinoma is modulated by SIRT2-mediated FOXO3 deacetylation.

Journal: BMC cancer
Published: June 24, 2019

EP300 and SIRT1/6 Co-Regulate Lapatinib Sensitivity Via Modulating FOXO3-Acetylation and Activity in Breast Cancer.

EP300 and SIRT1/6 Co-Regulate Lapatinib Sensitivity Via Modulating FOXO3-Acetylation and Activity in Breast Cancer.

Journal: Cancers
Published: June 05, 2019

Characterization of FOXO Acetylation.

Characterization of FOXO Acetylation.

Journal: Methods in molecular biology (Clifton, N.J.)
Published: November 11, 2018

FOXM1 modulates 5-fluorouracil sensitivity in cholangiocarcinoma through thymidylate synthase (TYMS): implications of FOXM1-TYMS axis uncoupling in 5-FU resistance.

FOXM1 modulates 5-fluorouracil sensitivity in cholangiocarcinoma through thymidylate synthase (TYMS): implications of FOXM1-TYMS axis uncoupling in 5-FU resistance.

Journal: Cell death & disease
Published: June 11, 2018

SUMOylation modulates FOXK2-mediated paclitaxel sensitivity in breast cancer cells.

SUMOylation modulates FOXK2-mediated paclitaxel sensitivity in breast cancer cells.

Journal: Oncogenesis
Published: September 26, 2017

The FOXO3-FOXM1 axis: A key cancer drug target and a modulator of cancer drug resistance.

The FOXO3-FOXM1 axis: A key cancer drug target and a modulator of cancer drug resistance.

Journal: Seminars in cancer biology
Published: July 03, 2017

p62/SQSTM1 interacts with vimentin to enhance breast cancer metastasis.

p62/SQSTM1 interacts with vimentin to enhance breast cancer metastasis.

Journal: Carcinogenesis
Published: March 04, 2017

Thienopyrimidinone Based Sirtuin-2 (SIRT2)-Selective Inhibitors Bind in the Ligand Induced Selectivity Pocket.

Thienopyrimidinone Based Sirtuin-2 (SIRT2)-Selective Inhibitors Bind in the Ligand Induced Selectivity Pocket.

Journal: Journal of medicinal chemistry
Published: January 31, 2017
Showing 1-10 of 10

Last Updated: 09/26/2026